NO20001169L - 6,9-bro erythromycinderivater - Google Patents

6,9-bro erythromycinderivater

Info

Publication number
NO20001169L
NO20001169L NO20001169A NO20001169A NO20001169L NO 20001169 L NO20001169 L NO 20001169L NO 20001169 A NO20001169 A NO 20001169A NO 20001169 A NO20001169 A NO 20001169A NO 20001169 L NO20001169 L NO 20001169L
Authority
NO
Norway
Prior art keywords
bridge
compound
pharmaceutically acceptable
effective amount
therapeutically effective
Prior art date
Application number
NO20001169A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001169D0 (no
Inventor
Yat Sun Or
Richard F Clark
Daniel T Chu
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20001169D0 publication Critical patent/NO20001169D0/no
Publication of NO20001169L publication Critical patent/NO20001169L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20001169A 1997-09-08 2000-03-07 6,9-bro erythromycinderivater NO20001169L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/925,582 US5780605A (en) 1997-09-08 1997-09-08 6,9-bridged erythromycin derivatives
PCT/US1998/018225 WO1999012947A1 (en) 1997-09-08 1998-09-01 6,9-bridged erythromycin derivatives

Publications (2)

Publication Number Publication Date
NO20001169D0 NO20001169D0 (no) 2000-03-07
NO20001169L true NO20001169L (no) 2000-04-05

Family

ID=25451953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001169A NO20001169L (no) 1997-09-08 2000-03-07 6,9-bro erythromycinderivater

Country Status (24)

Country Link
US (1) US5780605A (de)
EP (1) EP1015467B1 (de)
JP (1) JP2001515915A (de)
KR (1) KR20010023756A (de)
CN (1) CN1269803A (de)
AR (1) AR015434A1 (de)
AT (1) ATE257484T1 (de)
AU (1) AU9216298A (de)
BG (1) BG104288A (de)
BR (1) BR9812148A (de)
CA (1) CA2301643A1 (de)
CO (1) CO4970722A1 (de)
DE (1) DE69821009T2 (de)
DK (1) DK1015467T3 (de)
ES (1) ES2213915T3 (de)
HU (1) HUP0003571A2 (de)
IL (1) IL134220A0 (de)
NO (1) NO20001169L (de)
PL (1) PL339137A1 (de)
PT (1) PT1015467E (de)
SK (1) SK3032000A3 (de)
TR (1) TR200000620T2 (de)
WO (1) WO1999012947A1 (de)
ZA (1) ZA987688B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7464097B2 (en) * 2002-08-16 2008-12-09 Sap Ag Managing data integrity using a filter condition
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
CN1780846A (zh) * 2003-03-05 2006-05-31 Rib－X医药品有限公司 双官能杂环化合物及其制备和使用方法
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US20070270357A1 (en) * 2003-11-18 2007-11-22 Farmer Jay J Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
JP2008540432A (ja) * 2005-05-04 2008-11-20 エナンタ ファーマシューティカルズ インコーポレイテッド ６−１１橋かけオキシムエリスロマイシン誘導体
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
EP2203435B1 (de) * 2007-09-17 2018-07-18 Enanta Pharmaceuticals, Inc. 6, 11-gebrückte biaryl-makrolide
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6248696A (ja) * 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニル−ｌ−プロリンの製造法
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
CA2125478A1 (en) * 1992-01-21 1993-07-22 Paul A. Lartey 4"-deoxyerythromycin derivatives
DE69301916T2 (de) * 1992-04-22 1996-08-08 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo 5-0-desosaminylerythronolid a derivate
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5712253A (en) * 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B

Also Published As

Publication number Publication date
JP2001515915A (ja) 2001-09-25
WO1999012947A1 (en) 1999-03-18
ES2213915T3 (es) 2004-09-01
EP1015467A1 (de) 2000-07-05
KR20010023756A (ko) 2001-03-26
DK1015467T3 (da) 2004-05-03
PL339137A1 (en) 2000-12-04
BG104288A (bg) 2001-01-31
US5780605A (en) 1998-07-14
DE69821009T2 (de) 2004-11-18
EP1015467B1 (de) 2004-01-07
NO20001169D0 (no) 2000-03-07
DE69821009D1 (de) 2004-02-12
TR200000620T2 (tr) 2000-09-21
HUP0003571A2 (hu) 2001-02-28
PT1015467E (pt) 2004-05-31
CN1269803A (zh) 2000-10-11
AR015434A1 (es) 2001-05-02
SK3032000A3 (en) 2000-07-11
BR9812148A (pt) 2000-07-18
IL134220A0 (en) 2001-04-30
ATE257484T1 (de) 2004-01-15
ZA987688B (en) 1999-02-24
CA2301643A1 (en) 1999-03-18
AU9216298A (en) 1999-03-29
CO4970722A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
NO20001169L (no) 6,9-bro erythromycinderivater
NO20002099L (no) 6,11-bro-erytromycinderivater
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
DK0766672T3 (da) Arylsulfonamido-substituerede hydroxamsyrer som matrixmetallopreteinase-inhibitorer
PT1058683E (pt) Inibidores da farnesil-transferase com uma estrutura de piperidina e seu processo de preparacao
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
NO20001439L (no) 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
DE69508463D1 (de) Propiophenonderivate und Verfahren zu deren Herstellung
CA2307788A1 (en) 2-halo-6-o-substituted ketolide derivatives
PT928788E (pt) Compostos farmaceuticamente activos
WO2000026224A3 (en) Novel macrolide antibiotics
ZA911728B (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
CA2107223A1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
NO20053483L (no) 4-Anilinokinazolinderivater for behandling av unormal cellevekst
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
NO995842L (no) Multicykliske erytromycinderivater
NO323556B1 (no) Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.
NO992009L (no) Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
ATE89261T1 (de) Aryloxypropanolaminotetraline, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel.
CA2563965A1 (en) 6-0-substituted ketolides having antibacterial activity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application